152 related articles for article (PubMed ID: 6604303)
1. [Multiple sclerosis. Current status of research. I].
Lhermitte F; Lyon-Caen O
Rev Neurol (Paris); 1983; 139(5):323-33. PubMed ID: 6604303
[TBL] [Abstract][Full Text] [Related]
2. [Results of international multiple sclerosis research].
Bauer HJ
Wien Med Wochenschr; 1985 Jan; 135(1-2):2-5. PubMed ID: 2579510
[TBL] [Abstract][Full Text] [Related]
3. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
Madigand M; Fauchet R; Oger J; Sabouraud O
Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
[TBL] [Abstract][Full Text] [Related]
4. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
5. Role of viruses in the etiopathogenesis of multiple sclerosis.
Sarchielli P; Trequattrini A; Usai F; Murasecco D; Gallai V
Acta Neurol (Napoli); 1993 Oct; 15(5):363-81. PubMed ID: 8304085
[TBL] [Abstract][Full Text] [Related]
6. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
[TBL] [Abstract][Full Text] [Related]
7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
8. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
9. Studies of HLA antigens in multiple sclerosis.
Jersild C
Boll Ist Sieroter Milan; 1978 Jan; 56(6):516-30. PubMed ID: 415750
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis. I. The immune pathogenetic hypothesis.
Bergamini L; Durelli L
Riv Neurol; 1989; 59(5):176-90. PubMed ID: 2483961
[TBL] [Abstract][Full Text] [Related]
11. [Multiple sclerosis: molecular and cellular mechanisms].
Boĭko AN; Favorova OO
Mol Biol (Mosk); 1995; 29(4):727-49. PubMed ID: 7476940
[TBL] [Abstract][Full Text] [Related]
12. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
Béraud-Juven E
Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
[TBL] [Abstract][Full Text] [Related]
13. [Multiple sclerosis: results and prospects of research].
Zavalishin IA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):161-7. PubMed ID: 7041492
[TBL] [Abstract][Full Text] [Related]
14. HLA antigen segregation analysis in multiple sclerosis (MS) families.
Bertrams J; Kuwert E
Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
[TBL] [Abstract][Full Text] [Related]
15. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Johnson AJ; Suidan GL; McDole J; Pirko I
Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
[TBL] [Abstract][Full Text] [Related]
16. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
17. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
[TBL] [Abstract][Full Text] [Related]
18. The etiology and pathogenesis of multiple sclerosis: recent developments.
Raine CS
Pathobiol Annu; 1977; 7():347-84. PubMed ID: 339153
[No Abstract] [Full Text] [Related]
19. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
20. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
